Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Clinical trial NCT00745511 · UNKNOWN
Trial details
- NCT number
- NCT00745511
- Sponsor
- Ora Bio Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-06-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.